Clinical Trial Update: Inhaled Methoxyflurane for Pain Management in Nasal Bone Fracture Reduction [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update exploring inhaled methoxyflurane for acute pain management during nasal bone fracture reduction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasal Fracture
• Pain

Drugs mentioned

• Methoxyflurane (Methoxyflurane)

Snippet

Sponsor: Université de Sherbrooke | Conditions: Pain, Acute, Nasal Fracture | Phase 3 | Status: UNKNOWN